Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 11 2021
Historique:
received: 28 02 2021
accepted: 08 11 2021
entrez: 26 11 2021
pubmed: 27 11 2021
medline: 4 1 2022
Statut: epublish

Résumé

Mislocalization of the predominantly nuclear RNA/DNA binding protein, TDP-43, occurs in motor neurons of ~95% of amyotrophic lateral sclerosis (ALS) patients, but the contribution of axonal TDP-43 to this neurodegenerative disease is unclear. Here, we show TDP-43 accumulation in intra-muscular nerves from ALS patients and in axons of human iPSC-derived motor neurons of ALS patient, as well as in motor neurons and neuromuscular junctions (NMJs) of a TDP-43 mislocalization mouse model. In axons, TDP-43 is hyper-phosphorylated and promotes G3BP1-positive ribonucleoprotein (RNP) condensate assembly, consequently inhibiting local protein synthesis in distal axons and NMJs. Specifically, the axonal and synaptic levels of nuclear-encoded mitochondrial proteins are reduced. Clearance of axonal TDP-43 or dissociation of G3BP1 condensates restored local translation and resolved TDP-43-derived toxicity in both axons and NMJs. These findings support an axonal gain of function of TDP-43 in ALS, which can be targeted for therapeutic development.

Identifiants

pubmed: 34824257
doi: 10.1038/s41467-021-27221-8
pii: 10.1038/s41467-021-27221-8
pmc: PMC8617040
doi:

Substances chimiques

C9orf72 Protein 0
C9orf72 protein, human 0
DNA-Binding Proteins 0
Mitochondrial Proteins 0
Poly-ADP-Ribose Binding Proteins 0
RNA Recognition Motif Proteins 0
TARDBP protein, human 0
TDP-43 protein, mouse 0
DNA Helicases EC 3.6.4.-
G3bp1 protein, mouse EC 3.6.4.12
RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6914

Subventions

Organisme : Motor Neurone Disease Association
ID : TALBOT-MUTIHAC/APR15/832-791
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : TALBOT/OCT15/886-792
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Nat Med. 2018 Aug;24(8):1136-1142
pubmed: 29942091
Acta Neuropathol. 2015 Nov;130(5):643-60
pubmed: 26197969
Science. 2018 Mar 23;359(6382):1416-1421
pubmed: 29567716
Anal Chem. 2014 Nov 18;86(22):11033-7
pubmed: 25347402
Hum Mol Genet. 2020 Aug 3;29(13):2200-2217
pubmed: 32504093
Nat Methods. 2007 Jul;4(7):559-61
pubmed: 17558414
Eur J Cell Biol. 2016 Feb;95(2):69-88
pubmed: 26689471
Curr Protoc Cell Biol. 2018 Jun;79(1):e51
pubmed: 29924488
J Neurosci. 2010 Jan 13;30(2):639-49
pubmed: 20071528
J Neurosci. 2018 Jun 13;38(24):5478-5494
pubmed: 29773756
J Neurochem. 2008 May;105(3):797-806
pubmed: 18088371
Nat Neurosci. 2018 Mar;21(3):329-340
pubmed: 29463850
Nat Neurosci. 2019 Feb;22(2):180-190
pubmed: 30643298
J Neurol Sci. 1994 Jul;124 Suppl:96-107
pubmed: 7807156
Neuron. 2019 Apr 17;102(2):321-338.e8
pubmed: 30826182
Hum Mol Genet. 2012 Aug 15;21(16):3703-18
pubmed: 22641816
Hum Mol Genet. 2018 Feb 1;27(3):463-474
pubmed: 29194538
Neuron. 2014 Feb 5;81(3):536-543
pubmed: 24507191
J Cell Sci. 2015 Mar 15;128(6):1241-52
pubmed: 25632161
Nat Genet. 2008 May;40(5):572-4
pubmed: 18372902
Adv Neurobiol. 2018;20:283-301
pubmed: 29916024
J Neurosci. 2016 Jul 20;36(29):7707-17
pubmed: 27445147
Neuron. 2019 Mar 20;101(6):1057-1069
pubmed: 30897357
RNA. 2020 May;26(5):595-612
pubmed: 32051223
Sci Transl Med. 2020 Sep 2;12(559):
pubmed: 32878979
J Cell Sci. 2019 Dec 2;132(23):
pubmed: 31722980
Exp Neurol. 2018 Sep;307:155-163
pubmed: 29935168
Neuron. 2019 Sep 4;103(5):802-819.e11
pubmed: 31272829
Neuron. 2019 Apr 17;102(2):339-357.e7
pubmed: 30853299
Curr Biol. 2020 Dec 21;30(24):4882-4895.e6
pubmed: 33065005
Hum Mol Genet. 2017 Apr 15;26(8):1407-1418
pubmed: 28158562
Acta Neuropathol Commun. 2020 Jul 24;8(1):116
pubmed: 32709255
Neuron. 2018 Nov 21;100(4):816-830.e7
pubmed: 30344044
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Cell. 2019 Jan 10;176(1-2):73-84.e15
pubmed: 30612742
Brain. 2012 Nov;135(Pt 11):3380-91
pubmed: 23035040
Sci Rep. 2018 May 15;8(1):7551
pubmed: 29765078
Neural Regen Res. 2021 Jan;16(1):115-116
pubmed: 32788460
J Vis Exp. 2020 May 5;(159):
pubmed: 32449725
Sci Adv. 2018 Oct 10;4(10):eaat5847
pubmed: 30324134
Science. 2019 May 17;364(6441):
pubmed: 31097639
EMBO Rep. 2020 Aug 5;21(8):e48882
pubmed: 32558077
Dev Neurobiol. 2018 Mar;78(3):209-220
pubmed: 29115051
Science. 2015 Aug 7;349(6248):650-5
pubmed: 26250685
Cell. 2016 Jun 30;166(1):181-92
pubmed: 27321671
Nucleic Acids Res. 2016 Jan 4;44(D1):D1251-7
pubmed: 26450961
Cell Death Dis. 2019 Mar 1;10(3):210
pubmed: 30824685
Cell. 2019 Jan 10;176(1-2):56-72.e15
pubmed: 30612743
Nat Biomed Eng. 2019 Jan;3(1):13-14
pubmed: 30932066
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2466-E2475
pubmed: 28265061
J Biol Chem. 2019 Mar 8;294(10):3696-3706
pubmed: 30630951
Acta Neuropathol. 2020 Nov;140(5):695-713
pubmed: 32803350
Nat Neurosci. 2019 Feb;22(2):167-179
pubmed: 30643292
Nature. 2016 Nov 10;539(7628):197-206
pubmed: 27830784
J Neurobiol. 2006 May;66(6):522-36
pubmed: 16555236
Nucleic Acids Res. 2016 Dec 15;44(22):e165
pubmed: 27599845
J Mol Neurosci. 2011 Mar;43(3):470-7
pubmed: 21057983
Nat Neurosci. 2018 Feb;21(2):228-239
pubmed: 29311743
Nat Commun. 2018 Aug 22;9(1):3358
pubmed: 30135423
Anal Chem. 2003 Feb 1;75(3):663-70
pubmed: 12585499
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Methods Cell Biol. 2016;131:365-87
pubmed: 26794524
Sci Rep. 2018 Aug 23;8(1):12648
pubmed: 30140043
Cell. 2019 Sep 19;179(1):147-164.e20
pubmed: 31539493
Mol Neurodegener. 2020 Aug 15;15(1):45
pubmed: 32799899

Auteurs

Topaz Altman (T)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ariel Ionescu (A)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Amjad Ibraheem (A)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dominik Priesmann (D)

CECAD Research Center and Center for Molecular Medicine (CMMC), University of Cologne, 50931, Cologne, Germany.

Tal Gradus-Pery (T)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Luba Farberov (L)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gayster Alexandra (G)

Pathology Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Natalia Shelestovich (N)

Pathology Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Ruxandra Dafinca (R)

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Noam Shomron (N)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.

Florence Rage (F)

Institut de Génétique Moléculaire de Montpellier, IGMM UMR535, Montpellier, France.

Kevin Talbot (K)

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Michael E Ward (ME)

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Amir Dori (A)

Department of Neurology, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel.

Marcus Krüger (M)

CECAD Research Center and Center for Molecular Medicine (CMMC), University of Cologne, 50931, Cologne, Germany.

Eran Perlson (E)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. eranpe@tauex.tau.ac.il.
Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel. eranpe@tauex.tau.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH